The Cooper Companies, Inc. Common Stock (COO) Valuation

Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of sp...

The Cooper Companies, Inc. Common Stock (COO) currently trades at a P/E ratio of 59.32 (historical range: 30.06–63.89, median: 40.37), placing it at the 87th percentile — expensive relative to its history, P/S ratio of 3.31 (range: 2.73–5.86, 14th percentile — cheap relative to its history), EV/EBITDA of 89.70 (range: 23.68–120.27, 81th percentile).

The Cooper Companies, Inc. Common Stock appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.

Historical Valuation Metrics

MetricCurrentMinMedianMaxPercentileAssessment
P/E Ratio59.3230.0640.3763.8987thexpensive relative to its history
P/S Ratio3.312.733.785.8614thcheap relative to its history
EV/EBITDA89.7023.6847.63120.2781thexpensive relative to its history
FCF Yield0.020.010.010.0364thbelow its historical average
Current Price: $70.19
Market Cap: $13.7B
Sector: Healthcare